Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11,930 GBX | -0.81% | -3.48% | +12.55% |
09:56am | AstraZeneca drug lowers cholesterol in phase 1 trial | AN |
09:46am | Cellectis: operations financed until 2026 | CF |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.55% | 238B | |
+38.91% | 727B | |
+30.57% | 592B | |
-7.98% | 347B | |
+15.34% | 319B | |
-0.63% | 274B | |
+6.65% | 204B | |
-6.09% | 203B | |
-3.20% | 160B | |
-2.28% | 120B |
- Stock Market
- Equities
- AZN Stock
- News AstraZeneca PLC
- AstraZeneca Completes Gracell Biotechnologies Acquisition